在阿尔茨海默氏病中,HDAC6调节BACE1稳定性和NLRP3炎症酶激活
Jeongmi Lee1, Yongeun Cho1, Bo Youn Choi1
1School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Brain : a journal of neurology
|March 6, 2026
概括
基斯脱乙酶6 (HDAC6) 通过增加粉样β (Aβ) 生产和神经炎症驱动阿尔茨海默病. 在小鼠模型中,抑制HDAC6降低了Aβ,炎症,并改善了认知能力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默氏病 (AD) 的特点是粉样β (Aβ) 和tau病理,以及神经炎症.
- β位点APP分裂酶1 (BACE1) 驱动Aβ的产生,而NLRP3炎症体则调解微质炎症.
- 基因组脱乙酶6 (HDAC6) 在AD上调节,但其具体作用尚不清楚.
研究的目的:
- 为了研究海斯脱乙酶6 (HDAC6) 在阿尔茨海默氏病的发病过程中的作用.
- 为了确定HDAC6是否影响粉样β (Aβ) 生产和神经炎症.
主要方法:
- 研究了HDAC6对BACE1稳定性和活性的影响.
- 研究了HDAC6在微质中NLRP3炎症酶激活中的作用.
- 使用了具有HDAC6缺乏的5xFAD小鼠模型.
- 在小鼠大脑上进行了转录基因分析.
主要成果:
- HDAC6直接去乙化并稳定BACE1,增加Aβ的产生.
- HDAC6促进NLRP3炎症酶激活和微质中的IL-1β产生.
- 在5xFAD小鼠中,HDAC6缺乏减少了BACE1,Aβ沉积,炎症,并改善了认知功能.
- 转录组学表明,在HDAC6缺乏的小鼠中,质激活减少,突触通路增强.
结论:
- 在阿尔茨海默病中,HDAC6充当Aβ生产和神经炎症的双重调节者.
- HDAC6的目标是BACE1的稳定性和微质炎症酶激活.
- 抑制HDAC6是一种潜在的阿尔茨海默病治疗策略.
更多相关视频
09:52Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System
Published on: December 28, 2017
11.2K
09:20Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
9.0K
相关概念视频
Caspases
14.4K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Regulated Protein Degradation
3.3K
3.3K
Regulated Protein Degradation
9.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.1K
The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
